Cargando…
FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML
FOXM1, a known transcription factor, promotes cell proliferation in a variety of cancer cells. Here we show that Foxm1 is required for survival, quiescence and self-renewal of MLL-AF9 (MA9)-transformed leukemia stem cells (LSCs) in vivo. Mechanistically, Foxm1 upregulation activates the Wnt/β-cateni...
Autores principales: | Sheng, Yue, Yu, Chunjie, Liu, Yin, Hu, Chao, Ma, Rui, Lu, Xinyan, Ji, Peng, Chen, Jianjun, Mizukawa, Benjamin, Huang, Yong, Licht, Jonathan D., Qian, Zhijian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026046/ https://www.ncbi.nlm.nih.gov/pubmed/32066721 http://dx.doi.org/10.1038/s41467-020-14590-9 |
Ejemplares similares
-
Molecular pathogenesis of disease progression in MLL-rearranged AML
por: Kotani, Shinichi, et al.
Publicado: (2018) -
Foxm1 is essential for quiescence and maintenance of hematopoietic stem cells
por: Hou, Yu, et al.
Publicado: (2015) -
Initiation of MLL-rearranged AML is dependent on C/EBPα
por: Ohlsson, Ewa, et al.
Publicado: (2014) -
DOT1L Inhibition Sensitizes MLL-Rearranged AML to Chemotherapy
por: Liu, Wei, et al.
Publicado: (2014) -
The MLL–Menin Interaction is a Therapeutic Vulnerability in NUP98-rearranged AML
por: Rasouli, Milad, et al.
Publicado: (2023)